Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne F Jones

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancerPatricia M LoRusso, Suzanne F Jones, Kevin M Koch, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancerJeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
ESMO Open|August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohortHoward A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Clinical Advances in Hematology & Oncology : H&O|April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumorsSuzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabineJeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Targeted Oncology|November 19, 2024
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid TumorsManish R Patel, Gerald S Falchook, Judy S Wang, et al.
Cancer Investigation|October 14, 2015
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid TumorsJohanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Cancer|November 21, 2014
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumorsJohanna C Bendell, Manish R Patel, Jeffrey R Infante, et al.
Cancer|September 1, 2005
A Phase I trial of protracted oral fixed-dose temozolomideSuzanne F Jones, F Anthony Greco, Victor G Gian, et al.
The Oncologist|October 29, 2002
A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignanciesSuzanne F Jones, F Anthony Greco, John D Hainsworth, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancerPatricia M LoRusso, Suzanne F Jones, Kevin M Koch, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancerJeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
ESMO Open|August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohortHoward A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Clinical Advances in Hematology & Oncology : H&O|April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumorsSuzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabineJeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Targeted Oncology|November 19, 2024
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid TumorsManish R Patel, Gerald S Falchook, Judy S Wang, et al.
Cancer Investigation|October 14, 2015
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid TumorsJohanna C Bendell, Suzanne F Jones, Lowell Hart, et al.
Cancer|November 21, 2014
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumorsJohanna C Bendell, Manish R Patel, Jeffrey R Infante, et al.
Cancer|September 1, 2005
A Phase I trial of protracted oral fixed-dose temozolomideSuzanne F Jones, F Anthony Greco, Victor G Gian, et al.
The Oncologist|October 29, 2002
A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignanciesSuzanne F Jones, F Anthony Greco, John D Hainsworth, et al.
Pageof 7